Loss of prom-1 in a gld-1 or gld-2 mutant background resulted in the formation of a synthetic tumor, indicating that PROM-1 acts in parallel with the GLD-1 and GLD-2 pathways (Mohammad et al., 2018). The gene discussed is TENT2; the disease is neoplasm.